Trials4Health – Rebuttal Stage

Source-based overview

Trials4Health – Rebuttal Stage is a clinical research call from ERA4Health. This is not a new submission window: it is the rebuttal stage for invited full proposals from the existing Trials4Health call. It focuses on Investigator-initiated clinical trials; cardiovascular; autoimmune; metabolic diseases and is relevant to Participating ERA4Health countries. The recorded deadline or key date is Rebuttal stage 24 Aug–4 Sep 2026. Applicants should review the official page for the complete eligibility rules, required documents, assessment criteria, funding conditions, deadline time zone and submission route.

Eligibility

Eligible applicants and locations: Participating ERA4Health countries. Confirm any institutional, citizenship, career-stage and partnership requirements on the official call page.

Funding and benefits

See the official call page for funding and support details

Themes and supported activities

Investigator-initiated clinical trials; cardiovascular; autoimmune; metabolic diseases

Clinical Research Call

Participating ERA4Health countries

Deadline and timeline

Rebuttal stage 24 Aug–4 Sep 2026: Rebuttal stage 24 Aug–4 Sep 2026.

Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.

How to apply

Open the official call page, confirm the current requirements and deadline time zone, prepare the requested documents and submit through the funder or organiser's stated route.

Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.